π
|
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
52 auth.
J. Nangalia,
C. Massie,
E. Baxter,
Francesca L. Nice,
G. Gundem,
D. Wedge,
E. Avezov,
Juan Li,
K. Kollmann,
D. Kent,
Athar Aziz,
A. Godfrey,
Jonathon Hinton,
I. Martincorena,
P. Loo,
...
A. Jones,
P. Guglielmelli,
P. Tarpey,
H. Harding,
J. D. Fitzpatrick,
C. Goudie,
Christina A. Ortmann,
S. Loughran,
K. Raine,
David Jones,
A. Butler,
J. Teague,
S. OβMeara,
Stuart Mclaren,
M. Bianchi,
Y. Silber,
D. Dimitropoulou,
D. Bloxham,
L. Mudie,
M. Maddison,
B. Robinson,
C. Keohane,
C. Maclean,
K. Hill,
K. Orchard,
S. Tauro,
Ming-Qing Du,
M. Greaves,
D. Bowen,
B. Huntly,
C. Harrison,
Nicholas C. P. Cross,
D. Ron,
A. Vannucchi,
E. Papaemmanuil,
P. Campbell,
A. Green
|
10 |
2013 |
10 π
|
π
|
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
27 auth.
J. Grinfeld,
J. Nangalia,
J. Baxter,
D. Wedge,
Nicos Angelopoulos,
R. Cantrill,
A. Godfrey,
E. Papaemmanuil,
G. Gundem,
C. Maclean,
J. Cook,
Laura O'Neil,
S. OβMeara,
J. Teague,
A. Butler,
...
C. Massie,
N. Williams,
Francesca L. Nice,
C. Andersen,
H. Hasselbalch,
P. Guglielmelli,
M. McMullin,
A. Vannucchi,
C. Harrison,
M. Gerstung,
A. Green,
P. Campbell
|
8 |
2018 |
8 π
|
π
|
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort.
9 auth.
P. Campbell,
C. Maclean,
P. Beer,
G. Buck,
K. Wheatley,
J. Kiladjian,
...
C. Forsyth,
C. Harrison,
A. Green
|
7 |
2012 |
7 π
|
π
|
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
50 auth.
W. Tapper,
A. Jones,
R. Kralovics,
A. Harutyunyan,
K. Zoi,
W. Leung,
A. Godfrey,
P. Guglielmelli,
A. Callaway,
D. Ward,
P. Aranaz,
H. White,
K. Waghorn,
F. Lin,
A. Chase,
...
E. Joanna Baxter,
C. Maclean,
J. Nangalia,
E. Chen,
P. Evans,
M. Short,
A. Jack,
L. Wallis,
D. Oscier,
A. Duncombe,
A. Schuh,
A. Mead,
M. Griffiths,
J. Ewing,
R. Gale,
S. Schnittger,
T. Haferlach,
F. Stegelmann,
K. DΓΆhner,
H. Grallert,
K. Strauch,
Toshiko Tanaka,
S. Bandinelli,
A. Giannopoulos,
L. Pieri,
C. Mannarelli,
H. Gisslinger,
G. Barosi,
M. Cazzola,
A. Reiter,
C. Harrison,
P. Campbell,
A. Green,
A. Vannucchi,
N. Cross
|
7 |
2015 |
7 π
|
π
|
The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management
9 auth.
J. Yates,
C. Maclean,
J. Higgins,
Ayla Humphrey,
K. le MarΓ©chal,
Michelle Clifford,
...
I. Carcani-Rathwell,
J. Sampson,
P. Bolton
|
6 |
2011 |
6 π
|
π
|
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features
15 auth.
A. Godfrey,
P. Campbell,
C. Maclean,
G. Buck,
J. Cook,
J. Temple,
B. Wilkins,
K. Wheatley,
J. Nangalia,
J. Grinfeld,
...
M. McMullin,
C. Forsyth,
J. Kiladjian,
A. Green,
C. Harrison
|
5 |
2018 |
5 π
|
π
|
Intellectual development before and after the onset of infantile spasms: A controlled prospective longitudinal study in tuberous sclerosis
9 auth.
Ayla Humphrey,
C. Maclean,
G. Ploubidis,
Y. Granader,
Michelle Clifford,
Maisy Haslop,
...
B. Neville,
J. Yates,
P. Bolton
|
5 |
2014 |
5 π
|
π
|
Canadian Association of Radiologists Diagnostic Imaging Referral Guidelines: a guideline development protocol
14 auth.
Candyce Hamel,
R. Margau,
P. Pageau,
Marc Venturi,
Leila Esmaeilisaraji,
Barb Avard,
Sam Campbell,
Noel Corser,
Nicolas Dea,
Edmund Kwok,
...
C. Maclean,
Erin Sarrazin,
Charlotte J Yong-Hing,
K. Zaki-Metias
|
4 |
2023 |
4 π
|
π¬
|
Management of myelofibrosis: a survey of current practice in the United Kingdom
Moosa Qureshi,
C. Maclean,
M. McMullin,
C. Harrison
|
1 |
2012 |
1 π¬
|
π
|
The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients
51 auth.
C. Massie,
E. Baxter,
Francesca L. Nice,
G. Gundem,
D. Wedge,
E. Avezov,
Juan Li,
K. Kollmann,
D. Kent,
Athar Aziz,
A. Godfrey,
Jonathan Hinton,
I. Martincorena,
P. Loo,
A. Jones,
...
P. Guglielmelli,
P. Tarpey,
H. Harding,
J. D. Fitzpatrick,
C. Goudie,
Christina A. Ortmann,
S. Loughran,
K. Raine,
David T. Jones,
A. Butler,
J. Teague,
S. OβMeara,
Stuart Mclaren,
M. Bianchi,
Y. Silber,
Danai Dimitropolou,
D. Bloxham,
L. Mudie,
M. Maddison,
B. Robinson,
C. Keohane,
C. Maclean,
K. Hill,
K. Orchard,
S. Tauro,
M. Du,
M. Greaves,
D. Bowen,
B. Huntly,
C. Harrison,
N. Cross,
D. Ron,
A. Vannucchi,
E. Papaemmanuil,
P. Campbell,
A. Green
|
1 |
2013 |
1 π
|
π
|
Disease heterogeneity and personalized prognosis in myeloproliferative neoplasms
29 auth.
J. Grinfeld,
J. Nangalia,
E. Baxter,
D. Wedge,
Nicos Angelopoulos,
R. Cantrill,
A. Godfrey,
E. Papaemmanuil,
G. Gundem,
C. Maclean,
J. Cook,
L. Mudie,
S. OβMeara,
J. Teague,
A. Butler,
...
C. Massie,
N. Williams,
Francesca L. Nice,
C. Andersen,
H. Hasselbalch,
Paola,
Guglielmelli,
M. McMullin,
A. Vannucchi,
C. Harrison,
Moritz,
Gerstung,
A. Green,
P. Campbell
|
1 |
2018 |
1 π
|